Log In
BCIQ
Print this Print this
 

NMI-8000

  Manage Alerts
Collapse Summary General Information
Company Nemucore Medical Innovations Inc.
DescriptionMullerian inhibitory substance
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat chronic ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today